KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Finished Goods (2018 - 2025)

Globus Medical (GMED) has disclosed Finished Goods for 8 consecutive years, with $555.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Finished Goods changed 0.46% year-over-year to $555.7 million, compared with a TTM value of $555.7 million through Sep 2025, changed 0.46%, and an annual FY2024 reading of $491.5 million, down 30.53% over the prior year.
  • Finished Goods was $555.7 million for Q3 2025 at Globus Medical, roughly flat from $558.4 million in the prior quarter.
  • Across five years, Finished Goods topped out at $769.7 million in Q3 2023 and bottomed at $172.1 million in Q3 2021.
  • Average Finished Goods over 5 years is $390.0 million, with a median of $237.4 million recorded in 2023.
  • The sharpest move saw Finished Goods surged 273.12% in 2023, then tumbled 30.53% in 2024.
  • Year by year, Finished Goods stood at $177.8 million in 2021, then rose by 23.72% to $220.0 million in 2022, then skyrocketed by 221.64% to $707.5 million in 2023, then crashed by 30.53% to $491.5 million in 2024, then rose by 13.08% to $555.7 million in 2025.
  • Business Quant data shows Finished Goods for GMED at $555.7 million in Q3 2025, $558.4 million in Q2 2025, and $497.0 million in Q1 2025.